Cassie Jung - Jan 1, 2023 Form 3 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
SVP, Operations
Signature
/s/ Lori Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
3
Date filed
1/11/2023, 03:05 PM
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AQST Common Stock 36.7K Jan 1, 2023 Direct F1, F2
holding AQST Common Stock 2K Jan 1, 2023 By spouse
holding AQST Common Stock 44 Jan 1, 2023 By spouse IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AQST Non-Qualified Stock Option (right to buy) Jan 1, 2023 Common Stock 25K $3.84 Direct F3
holding AQST Non-Qualified Stock Option (right to buy) Jan 1, 2023 Common Stock 21K $5.69 Direct F4
holding AQST Non-Qualified Stock Option (right to buy) Jan 1, 2023 Common Stock 18.8K $4.07 Direct F5
holding AQST Non-Qualified Stock Option (right to buy) Jan 1, 2023 Common Stock 25K $0.88 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,567 shares acquired pursuant to the Company's employee stock purchase plan.
F2 Includes 15,000 restricted stock units ("RSUs"), which are scheduled to vest as follows: 3,750 on March 10, 2023, 3,750 on March 10, 2024 and 7,500 on March 10, 2025.
F3 Grant of non-qualified stock options, of which 25% vested on August 9, 2020, 25% vested on August 9, 2021, and 50% vested on August 9, 2022.
F4 Grant of non-qualified stock options, of which 25% vested on May 12, 2021, 25% vested on May 12, 2022, and 50% are scheduled to vest on May 12, 2023.
F5 Grant of non-qualified stock options, of which 25% vested on June 10, 2022, 25% are scheduled to vest on June 10, 2023, and 50% are scheduled to vest on June 10, 2024.
F6 Grant of non-qualified stock options, which are scheduled to vest as follows: 25% on August 5, 2023, 25% on August 5, 2024, and 50% on August 5, 2025.

Remarks:

Exhibit List Exhibit 24 -- Power of Attorney